U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07579897) titled 'Group vs. Individual Metacognitive Therapy for Generalized Anxiety Disorder' on April 09.
Brief Summary: Generalized anxiety disorder (GAD) is a serious and long-lasting condition that can greatly reduce quality of life, work functioning, and use of health services. Metacognitive therapy (MCT) is an effective treatment for GAD, but it is not yet known whether individual MCT or group-based MCT provides the best results for patients.
This randomized controlled trial will compare two formats of MCT: individual treatment and group-based treatment (g-MCT). A total of 64 adults with GAD (32 in each treatment arm) will participate after pr...